Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model
Pascal Häfliger, Julien Graff, Matthias Rubin, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
Pascal Häfliger, Roch‐Philippe Charles
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2428-2428
Open Access | Times Cited: 177
Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
Marianna Nachef, Alaa Kassim Ali, Saeedah Musaed Almutairi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 110
Clinical development of metabolic inhibitors for oncology
Kathryn M. Lemberg, Sadakatali S. Gori, Takashi Tsukamoto, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 1
Open Access | Times Cited: 99
Opsonization Inveigles Macrophages Engulfing Carrier‐Free Bilirubin/JPH203 Nanoparticles to Suppress Inflammation for Osteoarthritis Therapy
Huirong Huang, Shimin Zheng, Jianing Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 20
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc
Yongchan Lee, Pattama Wiriyasermkul, Chunhuan Jin, et al.
Nature Structural & Molecular Biology (2019) Vol. 26, Iss. 6, pp. 510-517
Open Access | Times Cited: 140
Amino acid transporters as emerging therapeutic targets in cancer
Yasuhiro Saito, Tomoyoshi Soga
Cancer Science (2021) Vol. 112, Iss. 8, pp. 2958-2965
Open Access | Times Cited: 68
Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy
Kiavash Hushmandi, Behzad Einollahi, Seyed Hassan Saadat, et al.
Molecular Metabolism (2024) Vol. 84, pp. 101952-101952
Open Access | Times Cited: 13
Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
Lili Quan, Ryuichi Ohgaki, Saori Hara, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 58
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Shagun Sharma, Navneet Agnihotri, Sandeep Kumar
Biochemical Pharmacology (2022) Vol. 198, pp. 114943-114943
Closed Access | Times Cited: 31
A novel therapeutic approach for anaplastic thyroid cancer through inhibition of LAT1
Keisuke Enomoto, Fuyuki Sato, Shunji Tamagawa, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma
Maihulan Maimaiti, Shinichi Sakamoto, Yasutaka Yamada, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 47
CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression
Sara Cano-Crespo, Juan J. Chillarón, Alexandra Junza, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 43
Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma
Kosuke Higuchi, Shinichi Sakamoto, Keisuke Ando, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 43
Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy
Ling Zhang, Chengguang Sui, Wenhan Yang, et al.
Asian Journal of Pharmaceutical Sciences (2020) Vol. 15, Iss. 2, pp. 192-206
Open Access | Times Cited: 41
The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer
Xinjie Lu
Current Cancer Drug Targets (2019) Vol. 19, Iss. 11, pp. 863-876
Closed Access | Times Cited: 40
Oncology Therapeutics Targeting the Metabolism of Amino Acids
Nefertiti Muhammad, Hyun Min Lee, Jiyeon Kim
Cells (2020) Vol. 9, Iss. 8, pp. 1904-1904
Open Access | Times Cited: 38
Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology
Stephen J. Fairweather, Nishank Shah, Stefan Bröer
Advances in experimental medicine and biology (2020), pp. 13-127
Closed Access | Times Cited: 33
Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
Kou Nishikubo, Ryuichi Ohgaki, Hiroki Okanishi, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 20, pp. 5246-5256
Open Access | Times Cited: 22
LAT1, a novel pharmacological target for the treatment of glioblastoma
Natalia Cappoli, Michael D. Jenkinson, Cinzia Dello Russo, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115103-115103
Closed Access | Times Cited: 20
Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent
Naoya Kondo, Fuko Hirano, Takashi Temma
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1106-1106
Open Access | Times Cited: 19
Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches
Sebastian Jakobsen, Carsten Uhd Nielsen
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 197-197
Open Access | Times Cited: 4
A Review on the Role of Human Solute Carriers Transporters in Cancer
Md. Shafiul Hossen, Mohammed Shafin Ul Islam, Mohammad Yasin Mohammad, et al.
Health Science Reports (2025) Vol. 8, Iss. 1
Open Access
Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1
Yang Wang, Liuxin Qin, Weiwei Chen, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113806-113806
Closed Access | Times Cited: 26
NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK
Françoise Cormier, Selma Housni, Florent Dumont, et al.
Oncogenesis (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Metabolic Reprogramming in Thyroid Cancer
Sang Hyeon Ju, Minchul Song, Joung Youl Lim, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 3, pp. 425-444
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top